Sugi Predict

Sugi Predict / Compounds / SCHEMBL760501

SCHEMBL760501

SCHEMBL760501

COC(=O)c1cc(B2OC(C)(C)C(C)(C)O2)cc2cn(Cc3ccc(OC)cc3)nc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.45
▸ HIF1A Q16665 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ SNCA P37840 2/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CACNA1G O43497 2/20 0.35
▸ CACNA1H O95180 2/20 0.35
▸ CACNA1I Q9P0X4 2/20 0.35
▸ PARP1 P09874 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10269727 0.88 UCHL1 (0.36) UCHL1ALDH1A1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL762095 0.80 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C19SMN1; SMN2KDM4E
SCHEMBL759896 0.79 UCHL1 (0.56) UCHL1HIF1ASNCACACNA1H
SCHEMBL369251 0.78 UCHL1 (0.53) UCHL1ALDH1A1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL30853389 0.78 DGAT1 (0.33) HIF1AKMT2A
SCHEMBL23514478 0.75 L3MBTL1 (0.43) ALDH1A1CYP1A2CYP2C19SMN1; SMN2KDM4E
SCHEMBL15182512 0.72 UCHL1 (0.52) UCHL1ALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL14404327 0.72 UCHL1 (0.46) UCHL1HIF1AALDH1A1CYP1A2CYP2C19
SCHEMBL6837142 0.71 UCHL1 (0.64) UCHL1ALDH1A1SMN1; SMN2KDM4EGLA
SCHEMBL1051278 0.71 UCHL1 (0.52) UCHL1ALDH1A1SMN1; SMN2KDM4ESNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 — — US disclosed
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 — — US disclosed
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 — — US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 — — US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 — — US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 — — US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 — — US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 — — US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 — — US disclosed
WO-2007117465-A2 INDAZOLE COMPOUNDS ABBOTT LABORATORIES (US) 2007-10-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282101-A1 Indazole compounds CYP3A43, CYP3A7, UGT1A1 UCHL1 4282/4885HIF1A 2537/4885ALDH1A1 89/4885
US-20120053345-A1 Indazole Compounds CYP3A43, CYP3A7, UGT1A1 UCHL1 4282/4885HIF1A 2537/4885ALDH1A1 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.